NCT02120066已完成不适用
Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 22
- 试验地点
- 1
- 主要终点
- Displacement of sub macular hemorrhage
研究概览
简要总结
Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 95 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms
排除标准
- •The eyes with preretinal or intraretinal hemorrhage at the fovea
- •The patients with follow-up less than 3 months
研究组 & 干预措施
Vitrectomy
Other
干预措施: Vitrectomy for submacular hemorrhage (Procedure)
Vitrectomy
Other
干预措施: subretinal injection of tissue-plasminogen activator (Drug)
结局指标
主要结局
Displacement of sub macular hemorrhage
时间窗: one year
Anatomical recovery detected funduscopy and optical coherence tomography
次要结局
- Visual acuity(one year)
研究者
Makoto Inoue
Associate professor of Ophthalmology
Kyorin University
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
1 期
Vitrectomy and subretinal TPA for submacular haemorrhage secondary to wet AMD (TIGER).Exudative age-related macular degenerationMedDRA version: 20.0Level: LLTClassification code: 10075718Term: Exudative age-related macular degeneration Class: 10015919CTIS2023-504751-28-00King's College London90
进行中（未招募）
1 期
A study of surgery to clear bleeding due to age-related macular degeneration.EUCTR2020-004917-10-DEKing's College London210
已完成
不适用
Autologous Plasmin-assisted Vitrectomy for Rhegmatogenous Retinal Detachmentinterventional study for the treatment of RRD (study is already completed)JPRN-UMIN000004615Department of Ophthalmology, Seoul National University Hospital7
Unknown
1 期
Clinical Study of Subretinal Transplantation of Human Embryo Stem Cell Derived Retinal Pigment Epitheliums in Treatment of Macular Degeneration DiseasesStargardt's Macular DystrophyMacular DegenerationNCT02749734Southwest Hospital, China15
暂停
不适用
rt-PA administration by retinal branch vein route for Central Retinal Vein Occlusion (CRVO). A Randomized - Conventional Therapy controlled – Trial.Central Retinal Vein Occlusion (CRVO)NL-OMON24763Oogziekenhuis RotterdamSchiedamsevest 1803011 BH Rotterdam48